메뉴 건너뛰기




Volumn 12, Issue 10 HCC, 2012, Pages 73-79

An overview of biomarkers for the diagnosis of hepatocellular carcinoma

Author keywords

Bioligical markers; Carcinoma; Diagnosis; Hepatocellular

Indexed keywords

ALPHA FETOPROTEIN; DECARBOXYPROTHROMBIN; GLYPICAN 3; GOLGI PROTEIN 73; HEAT SHOCK PROTEIN; MEMBRANE PROTEIN; MICRORNA; MUCIN 1; OSTEOPONTIN; SQUAMOUS CELL CARCINOMA ANTIGEN; TUMOR MARKER; UNCLASSIFIED DRUG;

EID: 84871506377     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: 10.5812/hepatmon.6122     Document Type: Article
Times cited : (36)

References (61)
  • 2
    • 11144316367 scopus 로고    scopus 로고
    • World Health Organization, updated 2010 February, Available from
    • World Health Organization. Mortality database. 2010 [updated 2010 February]; Available from: www.who.int/whosis/en.
    • (2010) Mortality Database
  • 3
    • 34250020201 scopus 로고    scopus 로고
    • Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis
    • El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132(7):2557-76.
    • (2007) Gastroenterology , vol.132 , Issue.7 , pp. 2557-2576
    • El-Serag, H.B.1    Rudolph, K.L.2
  • 4
    • 58149311491 scopus 로고    scopus 로고
    • Epidemiology of hepatitis viruses among hepatocellular carcinoma cases and healthy people in Egypt: A systematic review and meta-analysis
    • Lehman EM, Wilson ML. Epidemiology of hepatitis viruses among hepatocellular carcinoma cases and healthy people in Egypt: a systematic review and meta-analysis. Int J Cancer. 2009;124(3):690-7.
    • (2009) Int J Cancer , vol.124 , Issue.3 , pp. 690-697
    • Lehman, E.M.1    Wilson, M.L.2
  • 5
    • 34249699540 scopus 로고    scopus 로고
    • Non-alcoholic steatohepatitis and cancer
    • Bugianesi E. Non-alcoholic steatohepatitis and cancer. Clin Liver Dis. 2007;11(1):191-207, x-xi.
    • (2007) Clin Liver Dis , vol.11 , Issue.1 , pp. 191-207
    • Bugianesi, E.1
  • 7
    • 84871476235 scopus 로고    scopus 로고
    • National Cancer Registry of Egypt, updated 2010 August 6, Available from
    • National Cancer Registry of Egypt. Magnitude of hepatocellular carcinoma in Egypt. 2010 [updated 2010 August 6]; Available from: http://www.nci.cu.edu.eg/.
    • (2010) Magnitude of Hepatocellular Carcinoma In Egypt
  • 8
    • 42249105022 scopus 로고    scopus 로고
    • Egyptian Ministry of Health, updated 2010 July 6, Available from
    • Egyptian Ministry of Health. Egyptian Ministry of Health Annual Report. 2007 [updated 2010 July 6]; Available from: http://www.mohp.gov.eg/Main.asp.
    • (2007) Egyptian Ministry of Health Annual Report
  • 9
    • 77957112410 scopus 로고    scopus 로고
    • Seroprevalence of hepatitis C and B among blood donors in Egypt: Minya Governorate, 2000-2008
    • Khattab MA, Eslam M, Sharwae MA, Hamdy L. Seroprevalence of hepatitis C and B among blood donors in Egypt: Minya Governorate, 2000-2008. Am J Infect Control. 2010;38(8):640-1.
    • (2010) Am J Infect Control , vol.38 , Issue.8 , pp. 640-641
    • Khattab, M.A.1    Eslam, M.2    Sharwae, M.A.3    Hamdy, L.4
  • 10
    • 7044229778 scopus 로고    scopus 로고
    • Primary liver cancer: World-wide incidence and trends
    • Bosch FX, Ribes J, Diaz M, Cleries R. Primary liver cancer: world-wide incidence and trends. Gastroenterology. 2004;127(5 Suppl 1):S5-S16.
    • (2004) Gastroenterology , vol.127 , Issue.5 SUPPL. 1
    • Bosch, F.X.1    Ribes, J.2    Diaz, M.3    Cleries, R.4
  • 11
    • 63049133092 scopus 로고    scopus 로고
    • Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005
    • Altekruse SF, McGlynn KA, Reichman ME. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol. 2009;27(9):1485-91.
    • (2009) J Clin Oncol , vol.27 , Issue.9 , pp. 1485-1491
    • Altekruse, S.F.1    McGlynn, K.A.2    Reichman, M.E.3
  • 12
    • 79952231921 scopus 로고    scopus 로고
    • Management of hepatocellular carcinoma: An update
    • Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53(3):1020-2.
    • (2011) Hepatology , vol.53 , Issue.3 , pp. 1020-1022
    • Bruix, J.1    Sherman, M.2
  • 14
    • 80052841535 scopus 로고    scopus 로고
    • Gene signatures derived from a c-MET-driven liver cancer mouse model predict survival of patients with hepatocellular carcinoma
    • Ivanovska I, Zhang C, Liu AM, Wong KF, Lee NP, Lewis P, et al. Gene signatures derived from a c-MET-driven liver cancer mouse model predict survival of patients with hepatocellular carcinoma. PLoS One. 2011;6(9):e24582.
    • (2011) PLoS One , vol.6 , Issue.9
    • Ivanovska, I.1    Zhang, C.2    Liu, A.M.3    Wong, K.F.4    Lee, N.P.5    Lewis, P.6
  • 15
    • 0009679715 scopus 로고
    • Demonstration of a new protein fraction in serum from the human fetus
    • Bergstrand CG, Czar B. Demonstration of a new protein fraction in serum from the human fetus. Scand J Clin Lab Invest. 1956;8(2):174.
    • (1956) Scand J Clin Lab Invest , vol.8 , Issue.2 , pp. 174
    • Bergstrand, C.G.1    Czar, B.2
  • 16
    • 0014307002 scopus 로고
    • Production of embryonal serum alpha-globulin by hepatomas: Review of experimental and clinical data
    • Abelev GI. Production of embryonal serum alpha-globulin by hepatomas: review of experimental and clinical data. Cancer Res. 1968;28(7):1344-50.
    • (1968) Cancer Res , vol.28 , Issue.7 , pp. 1344-1350
    • Abelev, G.I.1
  • 17
    • 0027296563 scopus 로고
    • Sugar chains of human cord serum alpha-fetoprotein: Characteristics of N-linked sugar chains of glycoproteins produced in human liver and hepatocellular carcinomas
    • Yamashita K, Taketa K, Nishi S, Fukushima K, Ohkura T. Sugar chains of human cord serum alpha-fetoprotein: characteristics of N-linked sugar chains of glycoproteins produced in human liver and hepatocellular carcinomas. Cancer Res. 1993;53(13):2970-5.
    • (1993) Cancer Res , vol.53 , Issue.13 , pp. 2970-2975
    • Yamashita, K.1    Taketa, K.2    Nishi, S.3    Fukushima, K.4    Ohkura, T.5
  • 18
    • 47649102850 scopus 로고    scopus 로고
    • Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: New aspects and applications
    • Debruyne EN, Delanghe JR. Diagnosing and monitoring hepatocellular carcinoma with alpha-fetoprotein: new aspects and applications. Clin Chim Acta. 2008;395(1-2):19-26.
    • (2008) Clin Chim Acta , vol.395 , Issue.1-2 , pp. 19-26
    • Debruyne, E.N.1    Delanghe, J.R.2
  • 19
    • 0036741693 scopus 로고    scopus 로고
    • Screening for hepatocellular carcinoma
    • Koteish A, Thuluvath PJ. Screening for hepatocellular carcinoma. J Vasc Interv Radiol. 2002;13(9 Pt 2):S185-90.
    • (2002) J Vasc Interv Radiol , vol.13 , Issue.9 PT. 2
    • Koteish, A.1    Thuluvath, P.J.2
  • 20
    • 0034992615 scopus 로고    scopus 로고
    • Alpha-fetoprotein structure and function: Relevance to isoforms, epitopes, and conformational variants
    • Mizejewski GJ. Alpha-fetoprotein structure and function: relevance to isoforms, epitopes, and conformational variants. Exp Biol Med (Maywood). 2001;226(5):377-408.
    • (2001) Exp Biol Med (Maywood) , vol.226 , Issue.5 , pp. 377-408
    • Mizejewski, G.J.1
  • 21
    • 0020323447 scopus 로고
    • Regulation of human lymphocyte activation by alpha-fetoprotein. Evidence for selective suppression of Ia-associated T-cell proliferation in vitro
    • O'Neill G, Tsega E, Gold P, Murgita RA. Regulation of human lymphocyte activation by alpha-fetoprotein. Evidence for selective suppression of Ia-associated T-cell proliferation in vitro. Oncodev Biol Med. 1982;3(2-3):135-50.
    • (1982) Oncodev Biol Med , vol.3 , Issue.2-3 , pp. 135-150
    • O'Neill, G.1    Tsega, E.2    Gold, P.3    Murgita, R.A.4
  • 22
    • 0034749063 scopus 로고    scopus 로고
    • AFP-L3: A new generation of tumor marker for hepatocellular carcinoma
    • Li D, Mallory T, Satomura S. AFP-L3: a new generation of tumor marker for hepatocellular carcinoma. Clin Chim Acta. 2001;313(1-2):15-9.
    • (2001) Clin Chim Acta , vol.313 , Issue.1-2 , pp. 15-19
    • Li, D.1    Mallory, T.2    Satomura, S.3
  • 23
    • 67649305155 scopus 로고    scopus 로고
    • Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma
    • Marrero JA, Feng Z, Wang Y, Nguyen MH, Befeler AS, Roberts LR, et al. Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma. Gastroenterology. 2009;137(1):110-8.
    • (2009) Gastroenterology , vol.137 , Issue.1 , pp. 110-118
    • Marrero, J.A.1    Feng, Z.2    Wang, Y.3    Nguyen, M.H.4    Befeler, A.S.5    Roberts, L.R.6
  • 24
    • 12444342437 scopus 로고    scopus 로고
    • Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma
    • Soresi M, Magliarisi C, Campagna P, Leto G, Bonfissuto G, Riili A, et al. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma. Anticancer Res. 2003;23(2C):1747-53.
    • (2003) Anticancer Res , vol.23 , Issue.2 C , pp. 1747-1753
    • Soresi, M.1    Magliarisi, C.2    Campagna, P.3    Leto, G.4    Bonfissuto, G.5    Riili, A.6
  • 25
    • 0034122117 scopus 로고    scopus 로고
    • Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in cirrhotic patients undergoing liver transplantation
    • Gambarin-Gelwan M, Wolf DC, Shapiro R, Schwartz ME, Min AD. Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in cirrhotic patients undergoing liver transplantation. Am J Gastroenterol. 2000;95(6):1535-8.
    • (2000) Am J Gastroenterol , vol.95 , Issue.6 , pp. 1535-1538
    • Gambarin-Gelwan, M.1    Wolf, D.C.2    Shapiro, R.3    Schwartz, M.E.4    Min, A.D.5
  • 26
    • 58849159660 scopus 로고    scopus 로고
    • Evidence-based clinical practice guidelines for hepatocellular carcinoma in Japan: The J-HCC guidelines
    • Kokudo N, Makuuchi M. Evidence-based clinical practice guidelines for hepatocellular carcinoma in Japan: the J-HCC guidelines. J Gastroenterol. 2009;44(Suppl 19):119-21.
    • (2009) J Gastroenterol , vol.44 , Issue.19 SUPPL. , pp. 119-121
    • Kokudo, N.1    Makuuchi, M.2
  • 27
    • 0036215258 scopus 로고    scopus 로고
    • Early diagnosis of hepatocellular carcinoma using a sensitive assay for serum des-gamma-carboxy prothrombin: A prospective study
    • Ikoma J, Kaito M, Ishihara T, Nakagawa N, Kamei A, Fujita N, et al. Early diagnosis of hepatocellular carcinoma using a sensitive assay for serum des-gamma-carboxy prothrombin: a prospective study. Hepatogastroenterology. 2002;49(43):235-8.
    • (2002) Hepatogastroenterology , vol.49 , Issue.43 , pp. 235-238
    • Ikoma, J.1    Kaito, M.2    Ishihara, T.3    Nakagawa, N.4    Kamei, A.5    Fujita, N.6
  • 28
    • 14844290900 scopus 로고    scopus 로고
    • Des-gamma-carboxy prothrombin is a potential autologous growth factor for hepatocellular carcinoma
    • Suzuki M, Shiraha H, Fujikawa T, Takaoka N, Ueda N, Nakanishi Y, et al. Des-gamma-carboxy prothrombin is a potential autologous growth factor for hepatocellular carcinoma. J Biol Chem. 2005;280(8):6409-15.
    • (2005) J Biol Chem , vol.280 , Issue.8 , pp. 6409-6415
    • Suzuki, M.1    Shiraha, H.2    Fujikawa, T.3    Takaoka, N.4    Ueda, N.5    Nakanishi, Y.6
  • 29
    • 33947575209 scopus 로고    scopus 로고
    • Prognostic factors for portal venous invasion in patients with hepatocellular carcinoma
    • Hagiwara S, Kudo M, Kawasaki T, Nagashima M, Minami Y, Chung H, et al. Prognostic factors for portal venous invasion in patients with hepatocellular carcinoma. J Gastroenterol. 2006;41(12):1214-9.
    • (2006) J Gastroenterol , vol.41 , Issue.12 , pp. 1214-1219
    • Hagiwara, S.1    Kudo, M.2    Kawasaki, T.3    Nagashima, M.4    Minami, Y.5    Chung, H.6
  • 30
    • 0028291568 scopus 로고
    • Protein induced by vitamin K absence or antagonist II as a prognostic marker in hepatocellular carcinoma. Comparison with alpha-fetoprotein
    • Suehiro T, Sugimachi K, Matsumata T, Itasaka H, Taketomi A, Maeda T. Protein induced by vitamin K absence or antagonist II as a prognostic marker in hepatocellular carcinoma. Comparison with alpha-fetoprotein. Cancer. 1994;73(10):2464-71.
    • (1994) Cancer , vol.73 , Issue.10 , pp. 2464-2471
    • Suehiro, T.1    Sugimachi, K.2    Matsumata, T.3    Itasaka, H.4    Taketomi, A.5    Maeda, T.6
  • 31
    • 0035698289 scopus 로고    scopus 로고
    • Comparison of clinicopathological features of patients with hepatocellular carcinoma seropositive for alpha-fetoprotein alone and those seropositive for des-gamma-carboxy prothrombin alone
    • Okuda H, Nakanishi T, Takatsu K, Saito A, Hayashi N, Yamamoto M, et al. Comparison of clinicopathological features of patients with hepatocellular carcinoma seropositive for alpha-fetoprotein alone and those seropositive for des-gamma-carboxy prothrombin alone. J Gastroenterol Hepatol. 2001;16(11):1290-6.
    • (2001) J Gastroenterol Hepatol , vol.16 , Issue.11 , pp. 1290-1296
    • Okuda, H.1    Nakanishi, T.2    Takatsu, K.3    Saito, A.4    Hayashi, N.5    Yamamoto, M.6
  • 32
    • 31144478870 scopus 로고    scopus 로고
    • Prognostic significance of simultaneous measurement of three tumor markers in patients with hepatocellular carcinoma
    • Toyoda H, Kumada T, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, et al. Prognostic significance of simultaneous measurement of three tumor markers in patients with hepatocellular carcinoma. Clin Gastroenterol Hepatol. 2006;4(1):111-7.
    • (2006) Clin Gastroenterol Hepatol , vol.4 , Issue.1 , pp. 111-117
    • Toyoda, H.1    Kumada, T.2    Kiriyama, S.3    Sone, Y.4    Tanikawa, M.5    Hisanaga, Y.6
  • 33
    • 0037698789 scopus 로고    scopus 로고
    • Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients
    • Marrero JA, Su GL, Wei W, Emick D, Conjeevaram HS, Fontana RJ, et al. Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in american patients. Hepatology. 2003;37(5):1114-21.
    • (2003) Hepatology , vol.37 , Issue.5 , pp. 1114-1121
    • Marrero, J.A.1    Su, G.L.2    Wei, W.3    Emick, D.4    Conjeevaram, H.S.5    Fontana, R.J.6
  • 34
    • 34247874803 scopus 로고    scopus 로고
    • Des-gamma-carboxyl prothrombin-promoted vascular endothelial cell proliferation and migration
    • Fujikawa T, Shiraha H, Ueda N, Takaoka N, Nakanishi Y, Matsuo N, et al. Des-gamma-carboxyl prothrombin-promoted vascular endothelial cell proliferation and migration. J Biol Chem. 2007;282(12):8741-8.
    • (2007) J Biol Chem , vol.282 , Issue.12 , pp. 8741-8748
    • Fujikawa, T.1    Shiraha, H.2    Ueda, N.3    Takaoka, N.4    Nakanishi, Y.5    Matsuo, N.6
  • 35
    • 84857603190 scopus 로고    scopus 로고
    • Diagnostic and prognostic value of alpha-fetoprotein, des-gamma-carboxy prothrombin and squamous cell carcinoma antigen immunoglobulin M complexes in hepatocellular carcinoma
    • Bertino G, Neri S, Bruno CM, Ardiri AM, Calvagno GS, Malaguarnera M, et al. Diagnostic and prognostic value of alpha-fetoprotein, des-gamma-carboxy prothrombin and squamous cell carcinoma antigen immunoglobulin M complexes in hepatocellular carcinoma. Minerva Med. 2011;102(5):363-71.
    • (2011) Minerva Med , vol.102 , Issue.5 , pp. 363-371
    • Bertino, G.1    Neri, S.2    Bruno, C.M.3    Ardiri, A.M.4    Calvagno, G.S.5    Malaguarnera, M.6
  • 36
    • 33847231604 scopus 로고    scopus 로고
    • Clinical evaluation of lens culinaris agglutinin-reactive alpha-fetoprotein and des-gammacarboxy prothrombin in histologically proven hepatocellular carcinoma in the United States
    • Carr BI, Kanke F, Wise M, Satomura S. Clinical evaluation of lens culinaris agglutinin-reactive alpha-fetoprotein and des-gammacarboxy prothrombin in histologically proven hepatocellular carcinoma in the United States. Dig Dis Sci. 2007;52(3):776-82.
    • (2007) Dig Dis Sci , vol.52 , Issue.3 , pp. 776-782
    • Carr, B.I.1    Kanke, F.2    Wise, M.3    Satomura, S.4
  • 37
    • 34848886470 scopus 로고    scopus 로고
    • Clinical utility of AFP-L3% measurement in North American patients with HCV-related cirrhosis
    • Sterling RK, Jeffers L, Gordon F, Sherman M, Venook AP, Reddy KR, et al. Clinical utility of AFP-L3% measurement in North American patients with HCV-related cirrhosis. Am J Gastroenterol. 2007;102(10):2196-205.
    • (2007) Am J Gastroenterol , vol.102 , Issue.10 , pp. 2196-2205
    • Sterling, R.K.1    Jeffers, L.2    Gordon, F.3    Sherman, M.4    Venook, A.P.5    Reddy, K.R.6
  • 38
    • 58049200257 scopus 로고    scopus 로고
    • Utility of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxy prothrombin, alone or in combination, as biomarkers for hepatocellular carcinoma
    • Sterling RK, Jeffers L, Gordon F, Venook AP, Reddy KR, Satomura S, et al. Utility of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxy prothrombin, alone or in combination, as biomarkers for hepatocellular carcinoma. Clin Gastroenterol Hepatol. 2009;7(1):104-13.
    • (2009) Clin Gastroenterol Hepatol , vol.7 , Issue.1 , pp. 104-113
    • Sterling, R.K.1    Jeffers, L.2    Gordon, F.3    Venook, A.P.4    Reddy, K.R.5    Satomura, S.6
  • 39
    • 0034893110 scopus 로고    scopus 로고
    • Glypicans: Proteoglycans with a surprise
    • Filmus J, Selleck SB. Glypicans: proteoglycans with a surprise. J Clin Invest. 2001;108(4):497-501.
    • (2001) J Clin Invest , vol.108 , Issue.4 , pp. 497-501
    • Filmus, J.1    Selleck, S.B.2
  • 40
    • 51849088640 scopus 로고    scopus 로고
    • The role of glypican-3 in the regulation of body size and cancer
    • Filmus J, Capurro M. The role of glypican-3 in the regulation of body size and cancer. Cell Cycle. 2008;7(18):2787-90.
    • (2008) Cell Cycle , vol.7 , Issue.18 , pp. 2787-2790
    • Filmus, J.1    Capurro, M.2
  • 41
  • 42
    • 0038054270 scopus 로고    scopus 로고
    • Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker
    • Nakatsura T, Yoshitake Y, Senju S, Monji M, Komori H, Motomura Y, et al. Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker. Biochem Biophys Res Commun. 2003;306(1):16-25.
    • (2003) Biochem Biophys Res Commun , vol.306 , Issue.1 , pp. 16-25
    • Nakatsura, T.1    Yoshitake, Y.2    Senju, S.3    Monji, M.4    Komori, H.5    Motomura, Y.6
  • 43
    • 0038786861 scopus 로고    scopus 로고
    • Glypican-3: A novel serum and histochemical marker for hepatocellular carcinoma
    • Capurro M, Wanless IR, Sherman M, Deboer G, Shi W, Miyoshi E, et al. Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma. Gastroenterology. 2003;125(1):89-97.
    • (2003) Gastroenterology , vol.125 , Issue.1 , pp. 89-97
    • Capurro, M.1    Wanless, I.R.2    Sherman, M.3    Deboer, G.4    Shi, W.5    Miyoshi, E.6
  • 44
    • 0036614561 scopus 로고    scopus 로고
    • Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease
    • Kladney RD, Cui X, Bulla GA, Brunt EM, Fimmel CJ. Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease. Hepatology. 2002;35(6):1431-40.
    • (2002) Hepatology , vol.35 , Issue.6 , pp. 1431-1440
    • Kladney, R.D.1    Cui, X.2    Bulla, G.A.3    Brunt, E.M.4    Fimmel, C.J.5
  • 46
    • 27744539432 scopus 로고    scopus 로고
    • GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma
    • Marrero JA, Romano PR, Nikolaeva O, Steel L, Mehta A, Fimmel CJ, et al. GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma. J Hepatol. 2005;43(6):1007-12.
    • (2005) J Hepatol , vol.43 , Issue.6 , pp. 1007-1012
    • Marrero, J.A.1    Romano, P.R.2    Nikolaeva, O.3    Steel, L.4    Mehta, A.5    Fimmel, C.J.6
  • 48
    • 12444292158 scopus 로고    scopus 로고
    • Evaluation of serum KL-6 as a predictive marker of radiation pneumonitis in patients with breast-conservation therapy
    • Tokiya R, Hiratsuka J, Yoshida K, Imai S, Kajihara Y, Imajo Y. Evaluation of serum KL-6 as a predictive marker of radiation pneumonitis in patients with breast-conservation therapy. Int J Clin Oncol. 2004;9(6):498-502.
    • (2004) Int J Clin Oncol , vol.9 , Issue.6 , pp. 498-502
    • Tokiya, R.1    Hiratsuka, J.2    Yoshida, K.3    Imai, S.4    Kajihara, Y.5    Imajo, Y.6
  • 49
    • 30444433822 scopus 로고    scopus 로고
    • Assessment of KL-6 as a tumor marker in patients with hepatocellular carcinoma
    • Gad A, Tanaka E, Matsumoto A, Wahab MA, Serwah Ael H, Attia F, et al. Assessment of KL-6 as a tumor marker in patients with hepatocellular carcinoma. World J Gastroenterol. 2005;11(42):6607-12.
    • (2005) World J Gastroenterol , vol.11 , Issue.42 , pp. 6607-6612
    • Gad, A.1    Tanaka, E.2    Matsumoto, A.3    Wahab, M.A.4    Serwah, A.H.5    Attia, F.6
  • 50
    • 4344636664 scopus 로고    scopus 로고
    • Detection of serum and intrahepatic KL-6 in anti-HCV positive patients with hepatocellular carcinoma
    • Moriyama M, Matsumura H, Watanabe A, Nakamura H, Arakawa Y, Oshiro S, et al. Detection of serum and intrahepatic KL-6 in anti-HCV positive patients with hepatocellular carcinoma. Hepatol Res. 2004;30(1):24-33.
    • (2004) Hepatol Res , vol.30 , Issue.1 , pp. 24-33
    • Moriyama, M.1    Matsumura, H.2    Watanabe, A.3    Nakamura, H.4    Arakawa, Y.5    Oshiro, S.6
  • 51
    • 77949447135 scopus 로고    scopus 로고
    • Osteopontin: An effector and an effect of tumor metastasis
    • Shevde LA, Das S, Clark DW, Samant RS. Osteopontin: an effector and an effect of tumor metastasis. Curr Mol Med. 2010;10(1):71-81.
    • (2010) Curr Mol Med , vol.10 , Issue.1 , pp. 71-81
    • Shevde, L.A.1    Das, S.2    Clark, D.W.3    Samant, R.S.4
  • 52
    • 0038340658 scopus 로고    scopus 로고
    • Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma
    • Pan HW, Ou YH, Peng SY, Liu SH, Lai PL, Lee PH, et al. Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma. Cancer. 2003;98(1):119-27.
    • (2003) Cancer , vol.98 , Issue.1 , pp. 119-127
    • Pan, H.W.1    Ou, Y.H.2    Peng, S.Y.3    Liu, S.H.4    Lai, P.L.5    Lee, P.H.6
  • 53
    • 79959412687 scopus 로고    scopus 로고
    • Diagnostic significance of plasma osteopontin in hepatitis C virus-related hepatocellular carcinoma
    • Abu El Makarem MA, Abdel-Aleem A, Ali A, Saber R, Shatat M, Rahem DA, et al. Diagnostic significance of plasma osteopontin in hepatitis C virus-related hepatocellular carcinoma. Ann Hepatol. 2011;10(3):296-305.
    • (2011) Ann Hepatol , vol.10 , Issue.3 , pp. 296-305
    • Abu El Makarem, M.A.1    Abdel-Aleem, A.2    Ali, A.3    Saber, R.4    Shatat, M.5    Rahem, D.A.6
  • 54
    • 58149216066 scopus 로고    scopus 로고
    • Evaluation of serum squamous cell carcinoma antigen as a novel biomarker for diagnosis of hepatocellular carcinoma in Egyptian patients
    • Hussein MM, Ibrahim AA, Abdella HM, Montasser IF, Hassan MI. Evaluation of serum squamous cell carcinoma antigen as a novel biomarker for diagnosis of hepatocellular carcinoma in Egyptian patients. Indian J Cancer. 2008;45(4):167-72.
    • (2008) Indian J Cancer , vol.45 , Issue.4 , pp. 167-172
    • Hussein, M.M.1    Ibrahim, A.A.2    Abdella, H.M.3    Montasser, I.F.4    Hassan, M.I.5
  • 55
    • 33747415949 scopus 로고    scopus 로고
    • New frontiers in biomarkers for hepatocellular carcinoma
    • Giannelli G, Antonaci S. New frontiers in biomarkers for hepatocellular carcinoma. Dig Liver Dis. 2006;38(11):854-9.
    • (2006) Dig Liver Dis , vol.38 , Issue.11 , pp. 854-859
    • Giannelli, G.1    Antonaci, S.2
  • 56
    • 55249105722 scopus 로고    scopus 로고
    • Using proteomic approach to identify tumor-associated antigens as markers in hepatocellular carcinoma
    • Looi KS, Nakayasu ES, Diaz RA, Tan EM, Almeida IC, Zhang JY. Using proteomic approach to identify tumor-associated antigens as markers in hepatocellular carcinoma. J Proteome Res. 2008;7(9):4004-12.
    • (2008) J Proteome Res , vol.7 , Issue.9 , pp. 4004-4012
    • Looi, K.S.1    Nakayasu, E.S.2    Diaz, R.A.3    Tan, E.M.4    Almeida, I.C.5    Zhang, J.Y.6
  • 57
    • 0037223571 scopus 로고    scopus 로고
    • Expression profiling in multistage hepatocarcinogenesis: Identification of HSP70 as a molecular marker of early hepatocellular carcinoma
    • Chuma M, Sakamoto M, Yamazaki K, Ohta T, Ohki M, Asaka M, et al. Expression profiling in multistage hepatocarcinogenesis: identification of HSP70 as a molecular marker of early hepatocellular carcinoma. Hepatology. 2003;37(1):198-207.
    • (2003) Hepatology , vol.37 , Issue.1 , pp. 198-207
    • Chuma, M.1    Sakamoto, M.2    Yamazaki, K.3    Ohta, T.4    Ohki, M.5    Asaka, M.6
  • 58
    • 33646157967 scopus 로고    scopus 로고
    • Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues
    • Murakami Y, Yasuda T, Saigo K, Urashima T, Toyoda H, Okanoue T, et al. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene. 2006;25(17):2537-45.
    • (2006) Oncogene , vol.25 , Issue.17 , pp. 2537-2545
    • Murakami, Y.1    Yasuda, T.2    Saigo, K.3    Urashima, T.4    Toyoda, H.5    Okanoue, T.6
  • 59
    • 33749479908 scopus 로고    scopus 로고
    • Downregulation of miR-122 in the rodent and human hepatocellular carcinomas
    • Kutay H, Bai S, Datta J, Motiwala T, Pogribny I, Frankel W, et al. Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. J Cell Biochem. 2006;99(3):671-8.
    • (2006) J Cell Biochem , vol.99 , Issue.3 , pp. 671-678
    • Kutay, H.1    Bai, S.2    Datta, J.3    Motiwala, T.4    Pogribny, I.5    Frankel, W.6
  • 60
    • 77951620660 scopus 로고    scopus 로고
    • The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma
    • Shimizu S, Takehara T, Hikita H, Kodama T, Miyagi T, Hosui A, et al. The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma. J Hepatol. 2010;52(5):698-704.
    • (2010) J Hepatol , vol.52 , Issue.5 , pp. 698-704
    • Shimizu, S.1    Takehara, T.2    Hikita, H.3    Kodama, T.4    Miyagi, T.5    Hosui, A.6
  • 61
    • 33845790499 scopus 로고    scopus 로고
    • A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis
    • Llovet JM, Chen Y, Wurmbach E, Roayaie S, Fiel MI, Schwartz M, et al. A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis. Gastroenterology. 2006;131(6):1758-67.
    • (2006) Gastroenterology , vol.131 , Issue.6 , pp. 1758-1767
    • Llovet, J.M.1    Chen, Y.2    Wurmbach, E.3    Roayaie, S.4    Fiel, M.I.5    Schwartz, M.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.